Systemic lupus erythematosus: Predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: Multivariate analyses and identification of risk factors

Journal of Rheumatology

Volumn 23, Issue 3, 1996, Pages 469-475

  Calvo Alén, Jaime ^a   Alarcón, Graciela S ^a   Burgard, Sheila L ^a   Burst, Nickie ^a   Bartolucci, Alfred A ^a   Williams, H James ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Outcome; Predictors; SLE

Indexed keywords

AUTOANTIBODY;

ADULT; AGED; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS; COHORT STUDIES; DERMATOMYOSITIS; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RAYNAUD DISEASE; RISK FACTORS; SARCOIDOSIS; SCLERODERMA, SYSTEMIC;

EID: 0029897765     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Klemperer P, Pollack A, Baeh G: Diffuse collagen disease: Acute lupus erythematosus and diffuse scleroderma. JAMA 1942; 119:331-2.
2. Dubois EL: The relationship between systemic lupus erythematosus, progressive systemic sclerosis and mixed connective tissue disease. In. Dubois EL, ed. Systemic Lupus Erythematosus. Los Angeles: University Southern California Press, 1974.
3. LeRoy EC, Maricq H, Kahaleh M: Undifferentiated connective tissue disease syndrome. Arthritis Rheum 1980;23.341-3
4. Mukerji B, Hardin JG: Undifferentiated, overlapping and mixed connective tissue diseases. Am J Med Sci 1993;305:114-9.
5. Lockshin MD: What is SLE? J Rheumatol 1989;16:419-20.
6. Alarcón GS, Williams GV, Singer JZ. et al.: Early Undifferentiated connective tissue diseases I. Early clinical manifestations in a large cohort of patients with Undifferentiated connective tissue diseases compared with cohorts of well established connective tissue diseases. J Rheumatol 1997;18:1332-9.
7. Ropes MW, Bennet GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
8. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criterion Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
9. Tan EM, Cohen AS, Fries JE, et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982,25:1211-7
10. Bohan A, Peter JB, Bowman RL, Pearson CM: Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977;56:255-86.
11. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR: Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
12. Clegg DO, Williams HJ, Singer JZ, et al.: Early Undifferentiated connective tissue diseases. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 1997;18:1340-3.
13. Alarcón GS, Egger M, Williams HJ, Ward JR, for the Cooperative Systematic Studies of the Rheumatic Diseases Program Differential demographic and clinical features of patients with unexplained polyarthritis of less than 1 year symptom duration. Arthritis Rheum 1992;35:R8.
14. Alarcón GS, Schrohenloher RE, Morgan J, Egger M, Ward JR, Koopman WJ: IgM-rheumatoid factor as predictor to the occurrence of RA in a group of patients with unexplained polyarthritis from the Cooperative Systematic Studies of the Rheumatic Diseases program. Arthritis Rheum 1993;36:R21.
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J R Slat Soc 1955,53.457-81.
16. Cox DR: Regression models and life tables. J R Stat Soc 1972,34:187-200.
17. Sharp GC, Irvin WS, May CM, et al.: Association of antibodies to nbonucleoprotein and Sm antigens with mixed connective-tissue disease, systemic lupus erythematosus and other rheumatic diseases. N Eng J Med 1976;295:1149-54.
18. Lundberg I, Hedtfors E: Clinical course of patients with anti-RNP antibodies: A prospective study of 32 patients. J Rheumatol 1997;18:1511-9.
19. Lázaro MA, Maldonado-Cocco JA, Catoggio LJ, Babini SM, Messina OD, García Morteo O: Clinical and serological characteristics of patients with overlap syndrome: Is mixed connective tissue disease a distinct clinical entity? Medicine 1939;68:58-65.
20. Bulpitt KJ, Clements PJ, Lachenbruch PA. et al.: Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 1993;118:602-9.
21. Alarcón GS, Willkens RF, Egger MJ, et al.: Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared to cohorts of well established connective tissue diseases: Follow up data analyses in patients with unexplained polyarthritis and rheumatoid arthritis at baseline. Arthritis Rheum 1996;in press.
22. Michet CJ, McKenna CH, Elveback LR, Kaslow RA, Kurfand LT: Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin P roc 1985;60:105-13.
23. Siegel M, Lee SL: The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 1973;3:1-54.
24. Fessel WJ: Systemic lupus erythematosus in the community: Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974;134.1027-33.
25. Hochberg MC: The incidence of systemic lupus erythematosus in Baltimore, Maryland. Arthritis Rheum 1985;28:80-6.
26. Orens JB, Martinez FJ, Lynch JP III: Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin N Am 1994;20:159-93.
27. Hameenkorpi R, Ruuska P, Forsberg S, Tiilikainen R, Makitalo R, Hakala M: More evidence of distinctive features of mixed connective tissue disease. Scand J Rheumatol 1993;22:63-8.
28. Lom-Orta H, Alarcón-Segovia D, Díaz-Jouanen E: Systemic lupus erythematosus. Differences between patients who do not and those who do fulfill classification criteria at the time of diagnosis. J Rheumatol 1980;7:831-7.
29. Ganczarczyk L, Urowitz MB, Gladman DD: "Latent lupus". J Rheumatol 1989;16:475-8.
30. Greer JM, Panush RS: Incomplete lupus. Arch Intern Med 1989;149:2473-6.
31. Sontheimer RD, Gilliam JN: Systemic lupus erythematosus and the skin. In: Lahita RG, ed Systemic Lupus Erythematosus, 2nd ed. New York: Churchill Livingstone. 1992:657-81.
32. Tan EM, Chan EK, Sullivan KF, Rubin RL: Antinuclear antibodies: Diagnosticalty specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 1988;47:121-41.
33. Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J: Clinical significance of anti-RNP and anti-Sm antibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Clin Exp Immunol 1989;75:18-24.
34. Takeda Y, Wang GS, Wang RJ, et al.: Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol 1989;50:213-30.
35. Munves EF, Schur PH: Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum 1983;26:848-53.